Molecular hydrogen protects mice against polymicrobial sepsis by ameliorating endothelial dysfunction via an Nrf2/HO-1 signaling pathway.
Hongguang Chen, Keliang Xie, Huanzhi Han, Yuan Li, Lingling Liu, Tao Yang, Yonghao Yu · International immunopharmacology · 2015
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
The researchers found that both 0.3 mmol/L and 0.6 mmol/L (i.e., saturated) H₂-rich media improved cell viability and cellular apoptosis in LPS-activated HUVECs and that 0.6mmol/L (i.e., saturated) H₂-rich medium exerted an optimal effect. These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
What the Findings Mean
H2HUBB reviewed how molecular hydrogen was evaluated in this publication and summarizes the source-grounded findings below. The researchers found that both 0.3 mmol/L and 0.6 mmol/L (i.e., saturated) H₂-rich media improved cell viability and cellular apoptosis in LPS-activated HUVECs and that 0.6mmol/L (i.e., saturated) H₂-rich medium exerted an optimal effect.
What the Researchers Studied
The study used a preclinical animal experiment.
What Effects Did Molecular Hydrogen Have?
H₂ enhanced HO-1 expression and activity in vitro and in vivo. The researchers found that both 0.3 mmol/L and 0.6 mmol/L (i.e., saturated) H₂-rich media improved cell viability and cellular apoptosis in LPS-activated HUVECs and that 0.6mmol/L (i.e., saturated) H₂-rich medium exerted an optimal effect. The authors concluded that these results suggest that H₂ could suppress excessive inflammatory responses and endothelial injury via an Nrf2/HO-1 pathway. The researchers found that molecular hydrogen (H₂) exerts an anti-inflammatory effect.
Why These Findings Matter
These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
How Strong Is This Evidence?
This is preclinical animal evidence from a preclinical animal experiment. It is most informative for the disease model, mechanisms, biomarkers, and outcomes directly measured in the study.
Technical Study Details
H2HUBB classifies this publication as animal study with preclinical animal evidence. The study used a preclinical animal experiment.
Limitations and Safety
No separate limitations or safety findings were identified in the source text available to H2HUBB.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.